| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |